| Primary |
| Wound Treatment |
16.7% |
| Skin Fissures |
12.5% |
| Prophylaxis |
8.3% |
| Surgery |
8.3% |
| Dry Eye |
4.2% |
| Excoriation |
4.2% |
| Infection |
4.2% |
| Infection Prophylaxis |
4.2% |
| Nasal Cavity Packing |
4.2% |
| Postoperative Care |
4.2% |
| Skin Infection |
4.2% |
| Skin Laceration |
4.2% |
| Surgical Procedure |
4.2% |
| Surgical Site Reaction |
4.2% |
| Vaginal Douching |
4.2% |
| Wound |
4.2% |
| Wound Infection |
4.2% |
|
| Drug Hypersensitivity |
27.3% |
| Anaphylactic Reaction |
13.6% |
| Rash |
11.4% |
| Erythema |
6.8% |
| Agitation |
4.5% |
| Dermatitis Contact |
4.5% |
| Blood Creatinine Increased |
2.3% |
| Discomfort |
2.3% |
| Drug Ineffective |
2.3% |
| Eye Pain |
2.3% |
| Eye Swelling |
2.3% |
| Local Swelling |
2.3% |
| Loss Of Consciousness |
2.3% |
| Photophobia |
2.3% |
| Post Procedural Complication |
2.3% |
| Product Contamination |
2.3% |
| Product Quality Issue |
2.3% |
| Pruritus |
2.3% |
| Refusal Of Treatment By Patient |
2.3% |
| Skin Infection |
2.3% |
|
| Secondary |
| Maternal Exposure Timing Unspecified |
40.0% |
| Eye Disorder |
7.5% |
| Glaucoma |
7.5% |
| Eyelids Pruritus |
5.0% |
| Oropharyngeal Pain |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Pruritus |
5.0% |
| Anogenital Warts |
2.5% |
| Bacterial Infection |
2.5% |
| Catheter Site Discharge |
2.5% |
| Cough |
2.5% |
| Diabetic Neuropathy |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Eye Infection Bacterial |
2.5% |
| Hyperphosphataemia |
2.5% |
| Pyrexia |
2.5% |
| Sexual Dysfunction |
2.5% |
|
| Drug Hypersensitivity |
37.0% |
| Pruritus |
7.4% |
| Vomiting |
7.4% |
| Anaphylactic Reaction |
3.7% |
| Leukocytoclastic Vasculitis |
3.7% |
| Nausea |
3.7% |
| Pallor |
3.7% |
| Premature Baby |
3.7% |
| Pyrexia |
3.7% |
| Rash |
3.7% |
| Skin Disorder |
3.7% |
| Spherocytic Anaemia |
3.7% |
| Therapeutic Response Unexpected |
3.7% |
| Thrombocytopenia |
3.7% |
| Vision Blurred |
3.7% |
| Visual Impairment |
3.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
60.8% |
| Drug Use For Unknown Indication |
12.0% |
| Pain |
4.1% |
| Breast Cancer |
2.3% |
| Hypertension |
2.3% |
| Nausea |
2.0% |
| Sedation |
1.8% |
| Multiple Myeloma |
1.7% |
| Prophylaxis |
1.6% |
| Coronary Artery Bypass |
1.6% |
| Thrombosis Prophylaxis |
1.2% |
| Metastases To Bone |
1.1% |
| Anaesthesia |
1.0% |
| Diarrhoea |
1.0% |
| Anxiety |
1.0% |
| Constipation |
0.9% |
| Premedication |
0.9% |
| Diabetes Mellitus |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Acute Lymphocytic Leukaemia |
0.8% |
|
| Vomiting |
13.2% |
| Weight Decreased |
7.6% |
| Pulmonary Embolism |
6.9% |
| Wheezing |
6.9% |
| Pain |
5.6% |
| Injury |
4.9% |
| Shock |
4.9% |
| Urinary Tract Infection |
4.9% |
| Diarrhoea |
4.2% |
| Drug Ineffective |
4.2% |
| Grand Mal Convulsion |
4.2% |
| Renal Failure |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Anhedonia |
3.5% |
| Anxiety |
3.5% |
| Fear |
3.5% |
| Thrombocytopenia |
3.5% |
| Unevaluable Event |
3.5% |
| Unresponsive To Stimuli |
3.5% |
| Ventricular Arrhythmia |
3.5% |
|
| Interacting |
| Atrial Fibrillation |
50.0% |
| Limb Injury |
50.0% |
|
|
